Avondale Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-8,000
Closed -$121K – 129
2024
Q1
$121K Buy
+8,000
New +$145K 0.08% 56
2022
Q4
– Sell
-2,000
Closed -$51K – 126
2022
Q3
$51K Buy
+2,000
New +$70.2K 0.06% 73
2021
Q4
– Sell
-1,500
Closed -$190K – 116
2021
Q3
$190K Buy
1,500
+500
+50% +$72.8K 0.19% 48
2021
Q2
$166K Buy
+1,000
New +$162K 0.16% 47

Other funds holding TDOC

Avondale Wealth Management's TDOC Position: Q2 2024 in Review

Avondale Wealth Management sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 8,000 shares — an estimated $121K sold.

Avondale Wealth Management first reported a position in TDOC in Q2 2021 and held it in 4 quarters. The position peaked at $190K in Q3 2021. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Avondale Wealth Management reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Avondale Wealth Management sold 8,000 Teladoc Health shares in Q2 2024, an estimated $121K.
  • Avondale Wealth Management first reported a position in Teladoc Health in Q2 2021 and held it in 4 quarters.
  • Avondale Wealth Management's Teladoc Health position peaked at $190K in Q3 2021.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Avondale Wealth Management's 13F filing for Q2 2024, filed 12 Jul 2024.